fbpx

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Natus Medical, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BABY&src=ctag" target="_blank"gt;$BABYlt;/agt; lt;a href="https://twitter.com/hashtag/ClassAction?src=hash" target="_blank"gt;#ClassActionlt;/agt;–The
Schall Law Firm
, a national shareholder rights litigation firm,
announces that it is investigating claims on behalf of investors of
Natus Medical, Inc. (“Natus” or “the Company”) (NASDAQ: BABY)
for violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and
Exchange Commission.

The investigation focuses on whether the Company issued false and/or
misleading statements and/or failed to disclose information pertinent to
investors. GlassHouse Research published a report about Natus on
February 6, 2019, entitled, “Throw the BABY (Natus Medical Inc.) Out
with the Bathwater.” The report accused the Company of deceptive
accounting practices. Based on this report, shares of Natus fell by more
than 4% on the same day. Natus then announced on May 6, 2019, that it
would restate its financial results for the quarter ending March 31,
2019. The Company disclosed that the restatement was necessary because
“the Company identified non-cash currency translation adjustments and
related tax effects that should have been accounted for in connection
with the impairment charge for the divestiture of Medix.” Based on this
news, Natus fell in after-hours trading.

If you are a shareholder who suffered a loss, click
here to participate
.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of
the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA
90067, at 424-303-1964, to discuss your rights free of charge. You can
also reach us through the firm’s website at www.schallfirm.com,
or by email at [email protected].

The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If you
choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder rights
litigation.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and rules of ethics.

Contacts

The Schall Law Firm
Brian Schall, Esq.
Rina Restaino, Esq.
310-301-3335
Cell:
424-303-1964
[email protected]
www.schallfirm.com

LOS ANGELES–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BABY&src=ctag" target="_blank"gt;$BABYlt;/agt; lt;a href="https://twitter.com/hashtag/ClassAction?src=hash" target="_blank"gt;#ClassActionlt;/agt;–The
Schall Law Firm
, a national shareholder rights litigation firm,
announces that it is investigating claims on behalf of investors of
Natus Medical, Inc. (“Natus” or “the Company”) (NASDAQ: BABY)
for violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and
Exchange Commission.

The investigation focuses on whether the Company issued false and/or
misleading statements and/or failed to disclose information pertinent to
investors. GlassHouse Research published a report about Natus on
February 6, 2019, entitled, “Throw the BABY (Natus Medical Inc.) Out
with the Bathwater.” The report accused the Company of deceptive
accounting practices. Based on this report, shares of Natus fell by more
than 4% on the same day. Natus then announced on May 6, 2019, that it
would restate its financial results for the quarter ending March 31,
2019. The Company disclosed that the restatement was necessary because
“the Company identified non-cash currency translation adjustments and
related tax effects that should have been accounted for in connection
with the impairment charge for the divestiture of Medix.” Based on this
news, Natus fell in after-hours trading.

If you are a shareholder who suffered a loss, click
here to participate
.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of
the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA
90067, at 424-303-1964, to discuss your rights free of charge. You can
also reach us through the firm’s website at www.schallfirm.com,
or by email at [email protected].

The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If you
choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder rights
litigation.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and rules of ethics.

Contacts

The Schall Law Firm
Brian Schall, Esq.
Rina Restaino, Esq.
310-301-3335
Cell:
424-303-1964
[email protected]
www.schallfirm.com

leverton

Content is the most important part of having quality links to your website. With Area-Info.net, we provide a quality location to share your story and include links to your website to help you grow. If you would like to learn more, visit this page to see how you can use Area-Info.net to rank higher and quicker in search engines. Contact me directly at [email protected] with any questions, or to schedule speaking engagements.

You May Also Like